For the first time, WHO will endorse a new class of near point of care (NPOC) molecular tests designed to offer lower unit costs than existing molecular platforms.

WHO just signaled a major shift in global TB diagnostics — opening new strategic opportunities for molecular testing companies, investors, and global health implementers. In its upcoming guideline update, the World Health Organization will recommend: 🔹 A new class of near point-of-care molecular TB tests with lower unit costs 🔹 Tongue swab sampling to simplify access and eliminate sputum collection barriers 🔹 Sputum pooling strategies to reduce testing costs and expand throughput for TB and rifampicin-resistant TB These changes directly address persistent diagnostic gaps — especially in settings where sputum collection is difficult, lab infrastructure is limited, or testing costs restrict scale. For diagnostics manufacturers, global health donors, and national TB programs, this marks a major inflection point in technology adoption, procurement strategy, and competitive positioning.

---

What This Means for the Diagnostics Market • New product categories will gain WHO endorsement for the first time • Sample type innovation (tongue swabs) will reshape workflow and usability requirements • Cost-optimized testing strategies (pooling) will influence procurement and reimbursement • Near-patient molecular platforms will see accelerated demand in decentralized settings This is exactly the type of shift that requires custom, data-driven market intelligence.

---

How GRN IVD Consulting Helps At GRN IVD Consulting, we build custom-made market analyses tailored to your strategic needs — whether you are: • A diagnostics manufacturer evaluating entry into NPOC TB testing • An investor assessing market timing and competitive risk • A global health organization planning procurement or deployment • A BD team exploring partnerships, licensing, or regional expansion Our customized reports integrate: ✔ Market sizing & forecasting ✔ Competitive landscape mapping ✔ Technology differentiation & workflow analysis ✔ Policy & guideline impact modeling ✔ Country-level adoption barriers and accelerators ✔ Pricing, cost of goods, and procurement dynamics If your organization needs a precision-built market report aligned to your product, region, or investment thesis, GRN IVD Consulting can deliver it.